Aceso Life Science Group Limited (HKG:0474)
Hong Kong
· Delayed Price · Currency is HKD 0.119
-0.001 (-0.83%)
Mar 10, 2026, 9:59 AM HKT
Aceso Life Science Group Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Total Interest Expense | 107 | 124 | 143 | 140 | 154 | 191 | Upgrade
|
| Net Interest Income | -107 | -124 | -143 | -140 | -154 | -191 | Upgrade
|
| Other Revenue | 201 | 195 | 228 | 312 | 315 | 346 | Upgrade
|
| Revenue Before Loan Losses | 94 | 71 | 85 | 172 | 161 | 155 | Upgrade
|
| Provision for Loan Losses | 150 | 142 | 74 | -35 | -9 | 284 | Upgrade
|
| Revenue | -56 | -71 | 11 | 207 | 170 | -129 | Upgrade
|
| Revenue Growth (YoY) | - | - | -94.69% | 21.77% | - | - | Upgrade
|
| Cost of Services Provided | 251 | 219 | 235 | 294 | 299 | 288 | Upgrade
|
| Total Operating Expenses | 251 | 219 | 235 | 297 | 306 | 337 | Upgrade
|
| Operating Income | -307 | -290 | -224 | -90 | -136 | -466 | Upgrade
|
| Earnings From Equity Investments | -98 | -94 | -325 | -209 | -74 | 288 | Upgrade
|
| Currency Exchange Gain (Loss) | -5 | -6 | -4 | 12 | 9 | 5 | Upgrade
|
| EBT Excluding Unusual Items | -424 | -378 | -465 | -193 | -144 | -75 | Upgrade
|
| Gain (Loss) on Sale of Investments | -300 | -29 | -242 | -81 | -510 | -157 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -13 | Upgrade
|
| Other Unusual Items | - | - | - | 60 | 9 | -1 | Upgrade
|
| Pretax Income | -521 | -1,027 | -823 | -213 | -555 | -323 | Upgrade
|
| Income Tax Expense | -4 | -10 | -14 | -5 | 41 | 25 | Upgrade
|
| Earnings From Continuing Ops. | -517 | -1,017 | -809 | -208 | -596 | -348 | Upgrade
|
| Minority Interest in Earnings | 122 | 122 | 347 | -56 | 226 | -28 | Upgrade
|
| Net Income | -372 | -895 | -462 | -264 | -370 | -376 | Upgrade
|
| Net Income to Common | -372 | -895 | -462 | -264 | -370 | -376 | Upgrade
|
| Shares Outstanding (Basic) | 7,285 | 7,197 | 7,274 | 7,318 | 7,203 | 6,559 | Upgrade
|
| Shares Outstanding (Diluted) | 7,285 | 7,197 | 7,274 | 7,318 | 7,439 | 7,014 | Upgrade
|
| Shares Change (YoY) | 0.98% | -1.06% | -0.60% | -1.63% | 6.06% | 21.39% | Upgrade
|
| EPS (Basic) | -0.05 | -0.12 | -0.06 | -0.04 | -0.05 | -0.06 | Upgrade
|
| EPS (Diluted) | -0.05 | -0.12 | -0.06 | -0.04 | -0.06 | -0.06 | Upgrade
|
| Free Cash Flow | 116 | 15 | -48 | 190 | 259 | 164 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.00 | -0.01 | 0.03 | 0.04 | 0.02 | Upgrade
|
| Operating Margin | - | - | -2036.36% | -43.48% | -80.00% | - | Upgrade
|
| Profit Margin | - | - | -4200.00% | -127.54% | -217.65% | - | Upgrade
|
| Free Cash Flow Margin | - | - | -436.36% | 91.79% | 152.35% | - | Upgrade
|
Source: S&P Capital IQ. Financial Services template. Financial Sources.